Health ❯Public Health ❯Vaccines

mRNA Technology

Vaccine Development COVID-19 Vaccines Covid-19 Vaccines Public Trust Funding Decisions COVID-19 Response COVID-19 Vaccine Efficacy COVID-19 Pandemic Pandemic Preparedness Funding Issues Bird Flu

HHS Under Kennedy Pulls Back From mRNA, Winding Down 22 BARDA Projects

The redirection of nearly $500 million from BARDA projects prompts warnings about weakened outbreak readiness.

HHS Cancels $500M in mRNA Vaccine Contracts, Winding Down Respiratory Virus Efforts

RFK Jr. Terminates $500 Million in BARDA mRNA Vaccine Projects as Experts Warn of Consequences

HHS Withdraws $500 Million for mRNA Vaccine Research as Experts Warn of Pandemic Risks

GSK Secures $370 Million After CureVac US Patent Settlement

RFK Jr. Pulls $500M From mRNA Vaccine Projects, Draws Sharp Criticism

HHS Pulls Funding From 22 mRNA Vaccine Programs